135 related articles for article (PubMed ID: 10632777)
1. A new therapeutic approach to type II leprosy reaction.
Welsh O; Gómez M; Mancias C; Ibarra-Leal S; Millikan LE
Int J Dermatol; 1999 Dec; 38(12):931-3. PubMed ID: 10632777
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
3. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Naafs B
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
[No Abstract] [Full Text] [Related]
4. Azathioprine in controlling type 2 reactions in leprosy: a case report.
Athreya SP
Lepr Rev; 2007 Sep; 78(3):290-2. PubMed ID: 18035780
[No Abstract] [Full Text] [Related]
5. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
Sales AM; de Matos HJ; Nery JA; Duppre NC; Sampaio EP; Sarno EN
Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
[TBL] [Abstract][Full Text] [Related]
6. Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?
Mahajan VK; Chauhan PS; Sharma NL; Sharma AL; Mehta KS
Braz J Infect Dis; 2011; 15(1):90-1. PubMed ID: 21412598
[No Abstract] [Full Text] [Related]
7. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
Kar HK; Raina A; Sharma PK; Bhardwaj M
Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
9. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
10. [Histoid leprosy with erythema nodosum leprosum].
Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
[TBL] [Abstract][Full Text] [Related]
11. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
Pandhi D; Mehta S; Agrawal S; Singal A
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655
[TBL] [Abstract][Full Text] [Related]
12. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
Rattan R; Shanker V; Tegta GR; Verma GK
Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
[TBL] [Abstract][Full Text] [Related]
13. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
Rodríguez G; Pinto R; López F; Gómez Y
Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine as a steroid sparing agent in leprosy type 2 reactions: report of nine cases.
Durães SM; Salles Sde A; Leite VR; Gazzeta MO
Lepr Rev; 2011 Sep; 82(3):304-9. PubMed ID: 22125939
[No Abstract] [Full Text] [Related]
15. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
16. Vasculonecrotic reactions in leprosy.
Fogagnolo L; de Souza EM; Cintra ML; Velho PE
Braz J Infect Dis; 2007 Jun; 11(3):378-82. PubMed ID: 17684644
[TBL] [Abstract][Full Text] [Related]
17. Lepromatous leprosy in Saudi female from central region.
al-Majed S
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
[TBL] [Abstract][Full Text] [Related]
18. Histoid leprosy with erythema nodosum leprosum--a case report.
Vasavi S; Reddy BS
Indian J Lepr; 2012; 84(1):27-9. PubMed ID: 23077781
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
20. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]